News | Radiation Therapy | June 29, 2017

Multiple Uses for Gamma Knife to Drive Market Growth Through 2025

Multiple market reports indicate that as doctors discover new ways to utilize Gamma Knife radiosurgery, the global market for this innovative surgical method is growing.

Multiple Uses for Gamma Knife to Drive Market Growth Through 2025

June 29, 2017 — Due to its widespread success in treating several types of brain cancer, global market growth for Gamma Knife radiosurgery involving the head is expected to exceed $364.8 million by 2025. As more patients seek treatment at facilities that offer Gamma Knife radiosurgery, the market is forecast to grow at a compound annual growth rate (CAGR) of 9.2 percent, according to a new report from public relations firm OpenPR.

In terms of geographical location, North America has traditionally led market revenue share, accounting for over 29.2 percent of revenue in 2014, according to the report. A separate report from Future Market Insights indicates that by 2025, treatment of brain metastasis is expected to account for over $285.7 million in the United States market alone. However, as more patients worldwide are treated using Gamma Knife for a variety of medical conditions (for example, brain metastases, benign brain tumors such as pituitary adenomas, meningiomas and acoustic neuromas), both the European and Asia Pacific markets are expected to expand at CAGRs of 7.7 percent and 10.5 percent, respectively.(1)

A large part of this growth is the confirmation of the Gamma Knife an effective treatment option for a wide variety of medical conditions that benefit from a precision approach. Beyond its use as a successful therapy for metastatic brain tumors, the Gamma Knife has provided powerful results to patients suffering from trigeminal neuralgia, movement disorders and arteriovenous malformations, according to the San Diego Gamma Knife Center.

Kenneth Ott, MD, FACS, neurosurgeon at SDGKC, said, “The need for the radiosurgical treatment of metastatic brain tumors is vast and growing. Radiosurgery will also play an important part in the emerging field of neuro-augmentation. Stereotactic functional neurosurgery for pain, obsessive compulsive disorders, seizure disorders and other functional brain disorders will provide further patients to Gamma Knife facilities.”

Additionally, as more patients become aware of the advantages of radiosurgery, there is an increasing demand for this minimally invasive surgical method which has proven to be painless and less time-consuming. Support from governmental agencies, which are increasingly interested in initiatives focused on advancing the practice of radiosurgery, will further drive market growth as more healthcare facilities receiving government funding turn to the practice, according to the FMI report.

“As the nationwide cost of medical care and facilities continued to increase, it is increasingly important to healthcare facilities to provide cost-efficient treatment, such as radiosurgery,” said Ott. “Single treatment in a few hours, in an outpatient facility avoids the cost of in-patient care and the complications necessitated by open surgery. Patients are increasingly aware that co-pay and deductible costs are reduced with Gamma Knife radiosurgery.”

For more information: www.sandiegogammaknife.com

Related Content

Mevion Achieves CE Mark for S250i Proton Therapy System
News | Proton Therapy | November 21, 2017
November 21, 2017 — Mevion Medical Systems announced the Mevion S250i...
RayStation Selected for New Tennessee Proton Therapy Center
News | Treatment Planning | November 20, 2017
November 20, 2017 — Provision Healthcare has selected RayStation for external beam planning at the new Provision Care
Sponsored Content | Videos | Radiation Therapy | November 15, 2017
Chris Toth, president, global commercial and field operations for Varian, takes a tour of Varian’s new product introd
Synthetic CT Images Suitable for Prostate Cancer Radiotherapy Planning
News | Treatment Planning | November 14, 2017
Spectronic Medical announced that new data for their MRIPlanner software, generating synthetic computed tomography (sCT...
ASTRO: CMS Report on Radiation Therapy Payment Model Charts Path to Value-Based Cancer Care
News | Radiation Therapy | November 08, 2017
The American Society for Radiation Oncology (ASTRO) called on the Centers for Medicare and Medicaid Services (CMS) to...
U.S. Recognizes Radiologic Technologists Nov. 5-11
News | Imaging | November 06, 2017
November 6, 2017 — During National Radiologic Technology Week (NRTW) every November, hospitals, healthcare centers an
Study Suggests Breast Cancer Patients Forego Post-Surgery Treatment Due to Mistrust
News | Radiation Therapy | November 06, 2017
November 6, 2017 — Nearly one-third of women with...
PTCOG-NA Studies Address Cost and Coverage Issues With Proton Therapy
News | Proton Therapy | November 01, 2017
Physicians from across the country gathered in Chicago last week to discuss the most recent advances in proton therapy...
Proton Therapy Lowers Treatment Side Effects in Pediatric Head and Neck Cancer Patients
News | Proton Therapy | November 01, 2017
Pediatric patients with head and neck cancer can be treated with proton beam therapy (PBT) instead of traditional...
Cleveland Clinic Leads Development of New Guidelines for Radiation in Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | October 31, 2017
October 31, 2017 — Cleveland Clinic researcher Chirag Shah, M.D., recently led the development of updated guidelines
Overlay Init